Monoclonal antibody-based immunotherapy is now considered to be a main component of cancer therapy, alongside surgery, radiation, and chemotherapy. Monoclonal antibodies possess a diverse set of clinically relevant mechanisms of action.

Researchers can design antibodies that specifically target a certain antigen, such as one found on cancer cells. They can then make many copies of that antibody in the lab. These are known as monoclonal antibodies (mAbs or Moabs). Monoclonal antibodies are used to treat many diseases, including some types of cancer.

Monoclonal antibody drugs are treatments that enlist your body's germ-fighting immune system against diseases, including cancer. If your health care provider recommends a monoclonal antibody drug as part of your cancer treatment, find out what to expect from this therapy.

Feb 26, 2025 · Monoclonal antibodies (mAbs) are a type of cancer treatment. They may be called a type of targeted cancer drug or immunotherapy. But they can work in both ways. Find out more.

Monoclonal antibodies are immune system proteins that are created in the lab and used to treat cancer. Learn about monoclonal antibodies that can help turn the immune system against cancer, cancers that are treated with them, and the side effects they may cause.

Twenty-four monoclonal antibodies (mAbs) targeted to a total of 16 different antigens are currently approved for the treatment of an increasing number of cancers.

Aug 31, 2017 · Monoclonal antibodies — mAbs — are targeted therapies. They are used to treat a variety of types of cancer, as well as multiple sclerosis, rheumatoid arthritis and osteopenia. They work with the body’s immune system by disguising themselves as antibodies and triggering the body’s defense system to attack particular cells.

Monoclonal antibodies (mAbs) have varied therapeutic uses. It is possible to create a mAb that binds specifically to almost any extracellular target, such as cell surface proteins and cytokines.

Monoclonal antibodies (mAbs) have emerged as a major class of therapeutic agents on the market. To date, approximately 80 mAbs have been granted marketing approval. In 2018, 12 new mAbs were approved by the FDA, representing 20% of the total number of approved drugs.

Nov 10, 2020 · Monoclonal antibodies treat cancer as well as other illness by mimicking the body’s immune system. Learn how these drugs work, how they fit into cancer care and what research is underway from our Dr. Ecaterina Dumbrava.